Atrial Fibrosis: Translational Considerations for the Management of AF Patients

Código QR

Atrial Fibrosis: Translational Considerations for the Management of AF Patients

Guardado en:

Detalles Bibliográficos
Autores principales:	Stylianos Tzeis, Dimitrios Asvestas, Panos Vardas
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/9900fc3c344b49a0b5dd134718919492
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
por: Dominik Linz, et al.
Publicado: (2021)

CHARGE-AF in a national routine primary care electronic health records database in the Netherlands: validation for 5-year risk of atrial fibrillation and implications for patient selection in atrial fibrillation screening
por: Ralf E Harskamp, et al.
Publicado: (2021)

High-resolution Mapping in Patients with Persistent AF
por: Marius Andronache, et al.
Publicado: (2019)

Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)
por: David Ferreira, et al.
Publicado: (2021)

Atrial Tachycardias After Atrial Fibrillation Ablation: How to Manage?
por: Yuan Hung, et al.
Publicado: (2020)

AF in Cancer Patients: A Different Need for Anticoagulation?
por: Ana Pardo Sanz, et al.
Publicado: (2019)

Predictors of Recurrence of AF in Patients After Radiofrequency Ablation
por: Iskren Garvanski, et al.
Publicado: (2019)

The Evolving Role of Catheter Ablation in Patients With Heart Failure and AF
por: Sandeep Prabhu, et al.
Publicado: (2019)

Correction: CHARGE-AF in a national routineprimary care electronic health recordsdatabase in the Netherlands: validationfor 5-year risk of atrial fibrillation andimplications for patient selection inatrial fibrillation screening
Publicado: (2021)

Cardiac MRI to Manage Atrial Fibrillation
por: Yan Zhao, et al.
Publicado: (2020)

Individualised Approaches for Catheter Ablation of AF: Patient Selection and Procedural Endpoints
por: Nicolas Johner, et al.
Publicado: (2019)

The Convergent Atrial Fibrillation Ablation Procedure: Evolution of a Multidisciplinary Approach to Atrial Fibrillation Management
por: Karan Wats, et al.
Publicado: (2020)

Challenges Associated with Interpreting Mechanisms of AF
por: Caroline H Roney, et al.
Publicado: (2020)

Mapping and Imaging in Non-paroxysmal AF
por: Michael Ghannam, et al.
Publicado: (2019)

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation
por: Agnieszka Kotalczyk, et al.
Publicado: (2021)

Relationship Between Obstructive Sleep Apnoea and AF
por: Ghanshyam Shantha, et al.
Publicado: (2019)

Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
por: K Pukite, et al.
Publicado: (2020)

Understanding AF Mechanisms Through Computational Modelling and Simulations
por: Konstantinos N Aronis, et al.
Publicado: (2019)

Ivabradine and AF: Coincidence, Correlation or a New Treatment?
por: Mahmoud Abdelnabi, et al.
Publicado: (2020)

Atrial Myopathy Underlying Atrial Fibrillation
por: Harold Rivner, et al.
Publicado: (2020)

High-power, Short-duration Radiofrequency Ablation for the Treatment of AF
por: Irum D Kotadia, et al.
Publicado: (2020)

Rhythm Control in AF: Have We Reached the Last Frontier?
por: Gheorghe-Andrei Dan
Publicado: (2019)

Rhythm Control in Heart Failure Patients with Atrial Fibrillation
por: William Eysenck, et al.
Publicado: (2020)

Adoption of the SAMe-TT2R2 score in older patients with atrial fibrillation
por: Stylianos Tzeis, et al.
Publicado: (2021)

Atrial Tachycardias and Atypical Atrial Flutters: Mechanisms and Approaches to Ablation
por: Steven M Markowitz, et al.
Publicado: (2019)

Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
por: Yutao Guo, et al.
Publicado: (2020)

Redefining the Standard for Atrial Fibrillation: A Patient-centric Report
por: Carina Blomström Lundqvist, et al.
Publicado: (2021)

Redefining the Standard for Atrial Fibrillation: A Patient-centric Report
por: Carina Blomström Lundqvist, et al.
Publicado: (2021)

Rivaroxaban-Associated Bullous Pemphigoid in a Patient With Atrial Fibrillation
por: Jiaming (Calvin) Liang, MD, MSc, et al.
Publicado: (2021)

Sleep Apnoea and AF: Where Do We Stand? Practical Advice for Clinicians
por: Suneet Mittal, et al.
Publicado: (2021)

Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure
por: Michela Faggioni, et al.
Publicado: (2020)

Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention
por: Toka Hamaguchi, MD, et al.
Publicado: (2021)

Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management
por: Daniel TT Chong, et al.
Publicado: (2021)

Atrial Fibrillation and Oral Health
por: Amaar Hassan, et al.
Publicado: (2021)

Reconceptualising Atrial Fibrillation Using Renewal Theory: A Novel Approach to the Assessment of Atrial Fibrillation Dynamics
por: Jing Xian Quah, et al.
Publicado: (2021)

Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study
por: Shahrzad Salmasi, Msc, et al.
Publicado: (2021)

Cryoballoon Ablation of Atrial Fibrillation in Octogenarians
por: Tauseef Akhtar, et al.
Publicado: (2020)

The Next 10 Years in Atrial Fibrillation
por: Jeffrey L Turner, et al.
Publicado: (2019)

Atrial Fibrillation in Congenital Heart Disease
por: Irene Martín de Miguel, et al.
Publicado: (2021)

Residual Stroke Risk in Atrial Fibrillation
por: Wern Yew Ding
Publicado: (2021)